Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$27.03
-8.06%
Mkt Cap $2.59B
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$43.00
Range $30.00 – $56.00
Implied Upside
+59.1%
Consensus $43.00 vs current $27.03
NASDAQ·Healthcare·Biotechnology
$27.03
-8.06%
Mkt Cap $2.59B
No recent rating data.
Price Target (7 analysts)
$43.00
Range $30.00 – $56.00
+59.1%
Consensus $43.00 vs current $27.03